Telix Pharmaceuticals (TLPPF) News Today $13.08 +0.44 (+3.48%) (As of 07/5/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19, 2024 | investing.comTelix Pharmaceuticals plans Nasdaq listingMay 17, 2024 | finance.yahoo.comTelix Files Registration Statement for Proposed Initial Public Offering in the United StatesMay 17, 2024 | globenewswire.comTelix Files Registration Statement for Proposed Initial Public Offering in the United StatesApril 29, 2024 | seekingalpha.comCLRPF Clarity Pharmaceuticals LtdApril 18, 2024 | markets.businessinsider.comUBS Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)April 16, 2024 | finance.yahoo.comTelix Pharmaceuticals Limited (TLPPF)April 11, 2024 | finance.yahoo.comTelix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.April 11, 2024 | businesswire.comTelix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.March 21, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Tenaya Therapeutics (TNYA), Telix Pharmaceuticals Ltd. (TLPPF)March 18, 2024 | finance.yahoo.comQDOSE® Platform Partnership for Personalized Dosimetry in Radiopharmaceutical TherapyMarch 11, 2024 | finance.yahoo.comAppointment of Dr Darren Patti to Group Chief Operating OfficerMarch 5, 2024 | markets.businessinsider.comAustralian Stocks: Telix (TLX) Bolsters Supply Chain with AU$126M ARTMS DealFebruary 23, 2024 | markets.businessinsider.comStrong Buy Rating for Telix Pharmaceuticals Amidst Revenue Surge and Market Expansion OpportunitiesFebruary 22, 2024 | msn.comTelix Pharmaceuticals GAAP EPS of A$1.61, revenue of A$502.55MFebruary 7, 2024 | msn.comQSAM to be acquired by Telix for $33.1M plus $90M CVRJanuary 2, 2024 | morningstar.comTelix Pharmaceuticals Ltd Ordinary SharesDecember 26, 2023 | markets.businessinsider.comJefferies Reaffirms Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)December 25, 2023 | markets.businessinsider.comJefferies Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)December 11, 2023 | finance.yahoo.comFirst Patient Dosed in U.S. Expanded Access Program for TLX250-CDx, Telix's Breakthrough Kidney Cancer Imaging AgentDecember 6, 2023 | finance.yahoo.comPositive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer Presented at SABCSNovember 8, 2023 | finance.yahoo.comTelix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic RegionOctober 19, 2023 | msn.comTelix Pharmaceuticals reports Q3 resultsOctober 18, 2023 | finance.yahoo.comProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and TolerabilitySeptember 6, 2023 | finance.yahoo.comTelix to Showcase New ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EANMAugust 24, 2023 | markets.businessinsider.comWilsons Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)August 23, 2023 | msn.comTelix Pharmaceuticals reports 1H resultsAugust 23, 2023 | finance.yahoo.comTelix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage CompanyAugust 10, 2023 | finance.yahoo.comFirst Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese PatientsAugust 7, 2023 | prnewswire.comFirst Patient Dosed in IPAX-2 Study of TLX101 Brain Cancer Therapy Candidate in Patients with Newly Diagnosed GlioblastomaJuly 28, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Telix Pharmaceuticals Ltd. (TLPPF), Impedimed Limited (IPDQF)July 25, 2023 | markets.businessinsider.comTelix Pharmaceuticals Ltd. (TLPPF) Gets a Buy from Jarden Get Telix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Why Conservative Americans Are Turning to Gold in 2024 (Ad)Welcome to the financial rollercoaster of 2024, where inflation is relentless, stock markets are inflated, and global conflicts are escalating. Under Biden's disastrous policies, our savings are being devalued faster than ever. Protecting your wealth has never been more urgent. That's why we've created 3 Essential Guides to help you navigate these uncertain times and ensure your savings last as long as you do. Claim Your Kit Now TLPPF Media Mentions By Week TLPPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLPPF News Sentiment▼0.000.74▲Average Medical News Sentiment TLPPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLPPF Articles This Week▼00▲TLPPF Articles Average Week Get Telix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Arno Therapeutics News Today Artelo Biosciences News Today Ascletis Pharma News Today Awakn Life Sciences News Today AXIM Biotechnologies News Today BerGenBio ASA News Today BriaCell Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:TLPPF) was last updated on 7/6/2024 by MarketBeat.com Staff From Our PartnersWhy Conservative Americans Are Turning to Gold in 2024Welcome to the financial rollercoaster of 2024, where inflation is relentless, stock markets are inflated, and...All American Assets | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthles...Timothy Sykes | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLPPF Stock Alerts